A survey of population analysis methods and software for complex pharmacokinetic and pharmacodynamic models with examples
暂无分享,去创建一个
Robert J. Bauer | Serge Guzy | Chee Ng | C. Ng | S. Guzy | R. Bauer
[1] D. Bates,et al. Newton-Raphson and EM Algorithms for Linear Mixed-Effects Models for Repeated-Measures Data , 1988 .
[2] L Aarons,et al. Software for Population Pharmacokinetics and Pharmacodynamics , 1999, Clinical pharmacokinetics.
[3] Malcolm Rowland,et al. Reducing Whole Body Physiologically Based Pharmacokinetic Models Using Global Sensitivity Analysis: Diazepam Case Study , 2006, Journal of Pharmacokinetics and Pharmacodynamics.
[4] D J Roe. Comparison of population pharmacokinetic modeling methods using simulated data: results from the Population Modeling Workgroup. , 1997, Statistics in medicine.
[5] A. Joshi,et al. Pharmacokinetic–Pharmacodynamic–Efficacy Analysis of Efalizumab in Patients with Moderate to Severe Psoriasis , 2005, Pharmaceutical Research.
[6] E. Ette,et al. Designing Cross-Sectional Population Pharmacokinetic Studies: Implications for Pediatric and Animal Studies , 1996 .
[7] Goonaseelan Pillai,et al. Non-Linear Mixed Effects Modeling – From Methodology and Software Development to Driving Implementation in Drug Development Science , 2005, Journal of Pharmacokinetics and Pharmacodynamics.
[8] David J. Spiegelhalter,et al. Introducing Markov chain Monte Carlo , 1995 .
[9] F Mentré,et al. Population kinetics and conditional assessment of the optimal dosage regimen using the P-PHARM software package. , 1994, Anticancer research.
[10] Walter R. Gilks,et al. Full conditional distributions , 1995 .
[11] Leon Aarons. The estimation of population pharmacokinetic parameters using an EM algorithm. , 1993, Computer methods and programs in biomedicine.
[12] L. Skovgaard. NONLINEAR MODELS FOR REPEATED MEASUREMENT DATA. , 1996 .
[13] Ene I. Ette,et al. Analysis of animal pharmacokinetic data: Performance of the one point per animal design , 1995, Journal of Pharmacokinetics and Biopharmaceutics.
[14] Leon Aarons,et al. Propagation of Population Pharmacokinetic Information Using a Bayesian Approach: Comparison with Meta-Analysis , 2005, Journal of Pharmacokinetics and Pharmacodynamics.
[15] Stephen B Duffull,et al. ANALYSIS OF POPULATION PHARMACOKINETIC DATA USING NONMEM AND WinBUGS , 2004, Journal of biopharmaceutical statistics.
[16] Ivelina Gueorguieva,et al. Diazepam Pharamacokinetics from Preclinical to Phase I Using a Bayesian Population Physiologically Based Pharmacokinetic Model with Informative Prior Distributions in Winbugs , 2006, Journal of Pharmacokinetics and Pharmacodynamics.
[17] He Sun,et al. Balanced Designs in Longitudinal Population Pharmacokinetic Studies , 1998, Journal of clinical pharmacology.
[18] D. Bates,et al. Approximations to the Log-Likelihood Function in the Nonlinear Mixed-Effects Model , 1995 .
[19] David Z. D'Argenio,et al. Model for Intracellular Lamivudine Metabolism in Peripheral Blood Mononuclear Cells Ex Vivo and in Human Immunodeficiency Virus Type 1-Infected Adolescents , 2006, Antimicrobial Agents and Chemotherapy.
[20] David J. Spiegelhalter,et al. Estimation of population pharmacokinetics using the Gibbs sampler , 1995, Journal of Pharmacokinetics and Biopharmaceutics.
[21] Thomas M. Ludden,et al. Estimation of Population Pharmacokinetic Parameters in the Presence of Non-compliance , 2003, Journal of Pharmacokinetics and Pharmacodynamics.
[22] Lewis B. Sheiner,et al. Evaluation of methods for estimating population pharmacokinetic parameters. I. Michaelis-menten model: Routine clinical pharmacokinetic data , 1980, Journal of Pharmacokinetics and Biopharmaceutics.
[23] D. B. White,et al. An evaluation of point and interval estimates in population pharmacokinetics using Nonmem analysis , 1991, Journal of Pharmacokinetics and Biopharmaceutics.
[24] Jon Wakefield,et al. Bayesian Analysis of Population PK/PD Models: General Concepts and Software , 2002, Journal of Pharmacokinetics and Pharmacodynamics.
[25] F Mentré,et al. Hyperparameter estimation using stochastic approximation with application to population pharmacokinetics. , 1988, Biometrics.
[26] J F Boisvieux,et al. Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model. , 1984, Drug metabolism reviews.
[27] R. Gomeni,et al. A two-step iterative algorithm for estimation in nonlinear mixed-effect models with an evaluation in population pharmacokinetics. , 1995, Journal of biopharmaceutical statistics.
[28] D. Bates,et al. Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.
[29] Stephen G Walker,et al. AN EM ALGORITHM FOR NONLINEAR RANDOM EFFECTS MODELS , 1996 .
[30] Davide Verotta,et al. Pharmacokinetic–Pharmacodynamic Modelling: History and Perspectives , 2006, Journal of Pharmacokinetics and Pharmacodynamics.
[31] Siv Jönsson,et al. Estimating Bias in Population Parameters for Some Models for Repeated Measures Ordinal Data Using NONMEM and NLMIXED , 2004, Journal of Pharmacokinetics and Pharmacodynamics.
[32] Robert J. Bauer,et al. Monte Carlo Parametric Expectation Maximization (MC-PEM) Method for Analyzing Population Pharmacokinetic/Pharmacodynamic Data , 2004 .
[33] L B Sheiner,et al. Estimating population kinetics. , 1982, Critical reviews in biomedical engineering.